Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Juva Life Inc JUVAF

Juva Life Inc. is a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. It is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and recreational cannabis users. Juva Retail is a network of retail cannabis facilities that serves the San Francisco Bay Area and other areas. Juva Research researches and develops cannabis products to deliver the right medicine to the right patient at the right time. Juva Manufacturing create both Juva branded as well as white-label products for other recreational and medical related cannabis companies. Juva Distribution distributes Juva cultivated bulk cannabis, Juva branded products and may distribute products from other licensed cannabis companies.


GREY:JUVAF - Post by User

Post by Matteo1234on Oct 13, 2021 7:02am
170 Views
Post# 33999918

BIG NEWS ON JUVA $ 1 Billion market cap

BIG NEWS ON JUVA $ 1 Billion market capJust finshed watching a interview with CEO. He says that no news for months was on purpose. Along with the molecule Juva-019 that fights inflamation-they have identified other molecules and have received approval for testing. Their goal is to sell this discovery to a Drug Co, for between 1 billion to 5 billion. That would make anyone owning shares a instant millionaire. The interview can be found on U-tube. Stayhard
<< Previous
Bullboard Posts
Next >>